Imexpharm Corporation reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported revenue was VND 479,272.05 million compared to VND 314,245.19 million a year ago. Net income was VND 77,826.3 million compared to VND 52,601.31 million a year ago.

Basic earnings per share from continuing operations was VND 978.0952 compared to VND 660.9524 a year ago.